These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 12749599)
1. BCG vaccination and tuberculosis in Japan. Rahman M; Takahashi O; Goto M; Fukui T J Epidemiol; 2003 May; 13(3):127-35. PubMed ID: 12749599 [TBL] [Abstract][Full Text] [Related]
2. [Where do we stand with BCG vaccination programme in Japan?]. Mori T Kekkaku; 2001 Apr; 76(4):385-97. PubMed ID: 11398330 [TBL] [Abstract][Full Text] [Related]
3. Is Bacillus Calmette-Guerin revaccination necessary for Japanese children? Rahman M; Sekimoto M; Hira K; Koyama H; Imanaka Y; Fukui T Prev Med; 2002 Jul; 35(1):70-7. PubMed ID: 12079443 [TBL] [Abstract][Full Text] [Related]
4. A systematic review of BCG vaccination policies among high-risk groups in low TB-burden countries: implications for vaccination strategy in Canadian indigenous communities. Faust L; Schreiber Y; Bocking N BMC Public Health; 2019 Nov; 19(1):1504. PubMed ID: 31711446 [TBL] [Abstract][Full Text] [Related]
5. A cost-effectiveness analysis of universal versus selective immunization with Mycobacterium bovis bacille Calmette-Guérin in Finland. Hersh AL; Tala-Heikkilä M; Tala E; Tosteson AN; Fordham von Reyn C Int J Tuberc Lung Dis; 2003 Jan; 7(1):22-9. PubMed ID: 12701831 [TBL] [Abstract][Full Text] [Related]
6. Modelling the effect of discontinuing universal Bacillus Calmette-Guérin vaccination in an intermediate tuberculosis burden setting. Fu H; Lin HH; Hallett TB; Arinaminpathy N Vaccine; 2018 Sep; 36(39):5902-5909. PubMed ID: 30143270 [TBL] [Abstract][Full Text] [Related]
7. Assessing BCG vaccination coverage and incidence of paediatric tuberculosis following two major changes in BCG vaccination policy in France. Guthmann JP; Antoine D; Fonteneau L; Che D; Lévy-Bruhl D Euro Surveill; 2011 Mar; 16(12):. PubMed ID: 21457685 [TBL] [Abstract][Full Text] [Related]
8. Economic evaluation of universal BCG vaccination of Japanese infants. Rahman M; Sekimoto M; Takamatsu I; Hira K; Shimbo T; Toyoshima K; Fukui T Int J Epidemiol; 2001 Apr; 30(2):380-5. PubMed ID: 11369746 [TBL] [Abstract][Full Text] [Related]
9. Intradermal BCG: partial protection against tuberculosis in children: unproven efficacy of multipuncture administration. Prescrire Int; 2003 Dec; 12(68):226-9. PubMed ID: 14986698 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of the BCG revaccination programme in a cohort given BCG vaccination at birth in Hong Kong. Leung CC; Tam CM; Chan SL; Chan-Yeung M; Chan CK; Chang KC Int J Tuberc Lung Dis; 2001 Aug; 5(8):717-23. PubMed ID: 11495262 [TBL] [Abstract][Full Text] [Related]
11. Economic Evaluation of Selective Neonatal Bacillus Calmette-Guérin Vaccination of High-risk Infants in Ireland. Teljeur C; Moran PS; Harrington P; Butler K; Corcoran B; O'Donnell J; Usher C; O'Flanagan D; Connolly K; Ryan M Pediatr Infect Dis J; 2018 Aug; 37(8):759-767. PubMed ID: 29432385 [TBL] [Abstract][Full Text] [Related]
12. Assessing the effect of foreign travel and protection by BCG vaccination on the spread of tuberculosis in a low incidence country, United Kingdom, October 2008 to December 2009. Abubakar I; Matthews T; Harmer D; Okereke E; Crawford K; Hall T; Collyns T; Smith G; Barrett A; Baugh S Euro Surveill; 2011 Mar; 16(12):. PubMed ID: 21457684 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of BCG vaccination of the newborn: evaluation by a follow-up study of contacts in Bangui. Lanckriet C; Lévy-Bruhl D; Bingono E; Siopathis RM; Guérin N Int J Epidemiol; 1995 Oct; 24(5):1042-9. PubMed ID: 8557438 [TBL] [Abstract][Full Text] [Related]
15. [Amendment of tuberculosis prevention law and prospect of tuberculosis control program]. Ushio M Kekkaku; 2005 Jul; 80(7):541-6. PubMed ID: 16167781 [TBL] [Abstract][Full Text] [Related]
17. Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette-Guérin vaccination against tuberculosis. Abubakar I; Pimpin L; Ariti C; Beynon R; Mangtani P; Sterne JA; Fine PE; Smith PG; Lipman M; Elliman D; Watson JM; Drumright LN; Whiting PF; Vynnycky E; Rodrigues LC Health Technol Assess; 2013 Sep; 17(37):1-372, v-vi. PubMed ID: 24021245 [TBL] [Abstract][Full Text] [Related]
18. [Adverse events following immunization with BCG vaccine in Poland 1994-2000]. Szczuka I Przegl Epidemiol; 2002; 56(2):205-16. PubMed ID: 12371352 [TBL] [Abstract][Full Text] [Related]
19. Observational study to estimate the changes in the effectiveness of bacillus Calmette-Guérin (BCG) vaccination with time since vaccination for preventing tuberculosis in the UK. Mangtani P; Nguipdop-Djomo P; Keogh RH; Trinder L; Smith PG; Fine PE; Sterne J; Abubakar I; Vynnycky E; Watson J; Elliman D; Lipman M; Rodrigues LC Health Technol Assess; 2017 Jul; 21(39):1-54. PubMed ID: 28738015 [TBL] [Abstract][Full Text] [Related]
20. Safety and Immunogenicity of Early Bacillus Calmette-Guérin Vaccination in Infants Who Are Preterm and/or Have Low Birth Weights: A Systematic Review and Meta-analysis. Badurdeen S; Marshall A; Daish H; Hatherill M; Berkley JA JAMA Pediatr; 2019 Jan; 173(1):75-85. PubMed ID: 30476973 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]